Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05868161 · ClinicalTrials.gov registry record

Pounce™ Thrombectomy System Retrospective Registry

A clinical trial of Peripheral Arterial Disease and Acute Limb Ischemia, sponsored by SurModics.

Recruiting
Registry status
500
Enrollment target
9
Study locations

NCT05868161 is a study of Peripheral Arterial Disease and Acute Limb Ischemia that is actively recruiting participants, run by SurModics. The registered enrollment target is 500 participants, below the 4,200-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (88% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05868161, a study of Peripheral Arterial Disease and Acute Limb Ischemia, is actively recruiting participants, sponsored by SurModics.

RECRUITING
Registry status
500 participants
Enrollment target
9
Study locations

Study Summary

The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

Interventions

  • DEVICE Pounce Thrombectomy System

Study Locations (9)

Illinois

  • OSF St. Francis Medical Center - Peoria

Indiana

  • Community Hospital - Munster

Louisiana

  • Baton Rouge General Medical Center - Baton Rouge

Minnesota

  • Allina Health - Minneapolis

Ohio

  • Cleveland Clinic - Cleveland

South Carolina

  • Prisma Health Upstate - Greenville

South Dakota

  • North Central Heart - Sioux Falls

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-04-18
Est. Completion 2026-07-31

Sponsor

SurModics

4 total trials

What the Registry Record Tells You About NCT05868161

The ClinicalTrials.gov registry entry for NCT05868161 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,200-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (88% lower). The listed sponsor is SurModics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Pounce Thrombectomy System is the first listed.

NCT05868161 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Indiana, Louisiana.

Frequently Asked Questions

What is clinical trial NCT05868161 about?

NCT05868161 is a clinical study titled "Pounce™ Thrombectomy System Retrospective Registry". The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

What is the current status of trial NCT05868161?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-04-18. Estimated completion is 2026-07-31.

What conditions does trial NCT05868161 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease, Acute Limb Ischemia.

What interventions are being tested in trial NCT05868161?

The interventions under investigation include: Pounce Thrombectomy System (DEVICE).

Who is sponsoring clinical trial NCT05868161?

This trial is sponsored by SurModics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05868161 being conducted?

This trial has 9 study locations across Illinois, Indiana, Louisiana, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.